QRxPharma

Pharma

Actavis to refocus pain medication sales in QRxPharma licensing deal

Generic pharmaceutical manufacturer Actavis Group’s U.S. subsidiary has agreed to partner with clinical stage specialty pharmaceutical company QRxPharma in a licensing deal to commercialize acute pain medication MoxDuo IR in the United States, in a move that will reshape the Morristown, New Jersey company’s analgesic sales force for branded products. Under the terms of the […]